Thrombosis Research
Volume 124, Issue 4 , Pages 423-426 , September 2009

Haemostatic markers in patients with abdominal aortic aneurysm and the impact of aneurysm size

  • Jonas Wallinder

      Affiliations

    • Departments of Surgery, Sundsvall County Hospital, Sweden
    • ,
  • David Bergqvist

      Affiliations

    • Department of Surgical Sciences, Section of Vascular Surgery, Uppsala University Hospital, Sweden
    • ,
  • Anders E. Henriksson

      Affiliations

    • Laboratory Medicine, Sundsvall County Hospital, Sweden
    • Department of Surgical Sciences, Section of Vascular Surgery, Uppsala University Hospital, Sweden
    • Corresponding Author InformationCorresponding author. Department of Laboratory Medicine, Sundsvall County Hospital, SE-851 86 Sundsvall, Sweden. Tel.: +46 60 181379; fax: +46 60 182230.

Received 1 December 2008 ,Revised 19 January 2009 ,Accepted 31 January 2009.

References 

  1. Sakalihasan N, Limet R, Defawe OD. Abdominal aortic aneurysm. Lancet. 2005;365:1577–1589
  2. Lederle FA, Johnson GR, Wilson SE, Chute EP, Hye RJ, Makaroun MS, et al. The aneurysm detection and management study screening program. Arch Intern Med. 2000;160:1425–1430
  3. The UK Small Aneurysm Trial Participants . Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. The UK Small Aneurysm Trial Participants. Lancet. 1998;352:1649–1655
  4. Lederle FA, Wilson SE, Johnson GR, Reinke DB, Littooy FN, Acher CW, et al. Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med. 2002;346:1437–1444
  5. Brady AR, Fowkes FGR, Thompson SG, Powell JT. Aortic aneurysm diameter and risk of cardiovascular mortality. Artrioscler Thromb Vasc Biol. 2001;21:1203–1207
  6. Brady AR, Thompson SG, Fowkes FGR, Greenhalgh RM, Powell JT. Abdominal Aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation. 2004;110:16–21
  7. Powell JT, Brady AR. Detection, management, and prospects for medical treatment of small abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2004;24:241–245
  8. Lowe GDO, Yarnell JWG, Sweetnam PM, Rumley A, Thomas HF, Elwood PC. Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the Caerphilly Study. Thromb Haemost. 1998;79:129–133
  9. Lowe GD, Rumley A, Sweetnam PM, Yarnell JWG, Rumley J. Fibrin D-dimer, markers of coagulation activation and the risk of major ischemic heart disease in the Caerphilly Study. Thromb Haemost. 2001;86:822–827
  10. Morange PE, Bickel C, Nicaud V, Schnabel R, Rupprecht HJ, Peetz D, et al. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene Study. Arterioscler Thromb Vasc Biol. 2006;26:2793–2799
  11. Enderle MD, Pfohl M, Kellermann N, Haering HU, Hoffmeister HM. Endothelial function, variables of fibrinolysis and coagulation in smokers and healthy controls. Hemostasis. 2000;30:149–158
  12. Yarnell JW, Sweetnam PM, Rumley A, Lowe GD. Lifestyle factors and coagulation activation markers: the Caerphilly Study. Blood Coagul Fibrinolysis. 2001;12:721–728
  13. MacCallum PK. Markers of hemostasis and systemic inflammation in heart disease and atherosclerosis in smokers. Proc Am Thorac Soc. 2005;2:34–43
  14. Wannamethee SG, Lowe GDO, Shaper AG, Rumley A, Lennon L, Whincup PH. Association between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J. 2005;26:1765–1773
  15. Balduini CL, Salvini M, Montani N, Noris P, Spedini P, Belletti S, et al. Activation of the hemostatic process in patients with unruptured aortic aneurysm before and in the first week after surgical repair. Haematologica. 1997;82:581–583
  16. Yamazumi K, Ojiro M, Okumura H, Aikou T. An activated state of blood coagulation and fibrinolysis in patients with abdominal aortic aneurysm. Am J Surg. 1998;175:297–301
  17. Holmberg A, Siegbahn A, Westman B, Bergqvist D. Ischemia and reperfusion during open abdominal aortic aneurysm surgery induce extensive thrombin generation and activity. Eur J Vasc Endovasc Surg. 1999;18:11–16
  18. Wanhainen A, Nilsson TK, Bergqvist D, Boman K, Björck M. Elevated tissue plasminogen activator in patients with screening-detected abdominal aortic aneurysm. J Vasc Surg. 2007;45:1109–1113
  19. Grimes DA, Schulz KF. Compared to what? Finding controls for case-control studies. Lancet. 2005;365:1429–1433
  20. Choke E, Cockerill G, Wilson WRW, Sayed S, Dawson J, Loftus I, et al. A review of biological factors implicated in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg. 2005;30:227–244
  21. Tripodi A, Mannucci PM. Markers of activated coagulation and their usefulness in the clinical laboratory. Clin Chem. 1996;42:664–669
  22. Jean-Claude J, Newman KM, Li H, Gregory AK, Tilson MD. Possible key role for plasmin in the pathogenesis of abdominal aortic aneurysms. Surgery. 1994;116:472–478
  23. Touat Z, Ollivier V, Dai J, Huisse MG, Bezeaud A, Sebbag U, et al. Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution. Am J Pathol. 2006;168:1022–1030
  24. van der Putten RFM, Glatz JFC, Hermens WT. Plasma markers of activated hemostasis in the early diagnosis of acute coronary syndromes. Clin Chim Acta. 2006;371:37–54
  25. Bergqvist D, Björck M, Wanhainen A. Abdominal aortic aneurysm - to screen or not to screen. Eur J Vasc Endovasc Surg. 2008;35:13–18

PII: S0049-3848(09)00095-4

doi: 10.1016/j.thromres.2009.01.016

Thrombosis Research
Volume 124, Issue 4 , Pages 423-426 , September 2009

Article Tools